03.30.17
Ricardo Marek has been appointed president of Takeda Pharmaceuticals Emerging Markets Business Unit (EM BU), based in Singapore. Mr. Maretek will lead all business operations across five geographic areas that comprise EM BU – Asia Pacific (excluding Japan), China, Latin America, Middle East & Africa and Russia-CIS. He will also serve as a corporate officer and member of Takeda’s executive team, and report to Christophe Weber, president and chief executive officer of Takeda.
Mr. Marek joined the company in 2011 and became President of Takeda Brazil in 2013. He then took-on additional, concurrent responsibilities, as Area Head of Latin America (LatAm) in 2014. He will be relocating from São Paulo, Brazil, to Singapore and succeeds Giles Platford who has moved to Zurich as president of Europe and Canada.
“The Emerging Markets is one of Takeda’s core growth drivers. Ricardo’s success in delivering solid growth in Latin America over the last six years, coupled with his strong leadership skills and commercial acumen makes him well placed to lead this business unit,” commented Christophe Weber, President & CEO of Takeda. “Ricardo has an impressive track-record spanning over 15 years in leadership positions. I am confident he will continue to lead our teams to great success in their work to deliver better health and a brighter future to patients.”
Mr. Marek joined the company in 2011 and became President of Takeda Brazil in 2013. He then took-on additional, concurrent responsibilities, as Area Head of Latin America (LatAm) in 2014. He will be relocating from São Paulo, Brazil, to Singapore and succeeds Giles Platford who has moved to Zurich as president of Europe and Canada.
“The Emerging Markets is one of Takeda’s core growth drivers. Ricardo’s success in delivering solid growth in Latin America over the last six years, coupled with his strong leadership skills and commercial acumen makes him well placed to lead this business unit,” commented Christophe Weber, President & CEO of Takeda. “Ricardo has an impressive track-record spanning over 15 years in leadership positions. I am confident he will continue to lead our teams to great success in their work to deliver better health and a brighter future to patients.”
